NL-OMON26720尚未招募不适用
Efficacy of hepatitis A vaccination in immunocompromised travelers.
no sponsorfund=initiator=sponsor0 个研究点目标入组 600 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 600
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. All consecutive patients > 18 years of age using immunosuppressive medication who come to the travel clinics and need vaccination with hepatitis A according to LCR guidelines.
- •- Immunosuppressive medication is defined as use of cyclosporine A, azathioprine, cyclophosphamide, methotrexate, TNF-á blockers, prednisone use eqal to 10 mg/day or a cumulative dose of > 700 mg., tacrolimus, mycophenolate mofetil.
排除标准
- •1. Allergy to the advised vaccine or its components.
研究者
相似试验
招募中
4 期
Immunogenicity of live attenuated hepatitis A vaccine in overweight and obese children/adolescent/young adultOverweight or obesityHepatitis A vaccine,immunogenicity,overweight,obesityTCTR20191230001BIOGENETECH CO., LTD.200
进行中(未招募)
不适用
Hepatitis A vaccine in patients with immunomodulative drugsPatients with rheumatoid arthritis treated with immunosuppressive medicationMedDRA version: 12.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisMedDRA version: 12.1Level: LLTClassification code 10054980Term: Immunosuppressant drug therapyMedDRA version: 12.1Level: LLTClassification code 10063430Term: Hepatitis A immunisationEUCTR2009-016055-22-SEHY, HUS380
招募中
4 期
How well is the efficacy of hepatitis A vaccination in elderly people?hepatitis A vaccinationjaundice10047438NL-OMON34411Alysis Zorggroep60
已完成
3 期
Immunogenicity and Safety of Inactivated and Live-attenuated HAV Vaccine Among Thai Healthy Children and AdolescentsHAVHep AVaccine-Preventable DiseasesHepatitis ANCT06298708Chiang Mai University120
已完成
4 期
Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) PatientsUlcerative ColitisCrohn's DiseaseHepatitis AInflammatory Bowel DiseaseNCT01341808Asan Medical Center493
